August J Moretti is Chief Financial Officer of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 11,045 shares of FDMT, which is worth approximately $61,299. The most recent transaction as insider was on May 15, 2023, when has been sold 3,000 shares (Common Stock) at a price of $9.41 per share, resulting in proceeds of $28,230. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11K
0% 3M change
0% 12M change
Total Value Held $61,299

August J Moretti Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2023
BUY
Exercise of conversion of derivative security
$28,230 $9.41 p/Share
3,000 Added 21.36%
11,045 Common Stock
Dec 21 2022
BUY
Exercise of conversion of derivative security
$28,230 $9.41 p/Share
3,000 Added 31.27%
6,595 Common Stock
Apr 12 2021
BUY
Exercise of conversion of derivative security
$9,410 $9.41 p/Share
1,000 Added 33.33%
2,000 Common Stock

Also insider at

CLXT
Calyxt, Inc. Consumer Defensive
AJM

August J Moretti

Chief Financial Officer
Emeryville, CA

Track Institutional and Insider Activities on FDMT

Follow 4D Molecular Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

News

Receive news related to 4D Molecular Therapeutics, Inc.

Track Activities on FDMT